tiprankstipranks
Trending News
More News >
Perspective Therapeutics (CATX)
:CATX
US Market

Perspective Therapeutics (CATX) Income Statement

Compare
1,552 Followers

Perspective Therapeutics Income Statement

Last quarter (Q2 2025), Perspective Therapeutics's total revenue was $290.00K, an increase of Infinity% from the same quarter last year. In Q2, Perspective Therapeutics's net income was $-21.48M. See Perspective Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.43M$ 7.10M$ 10.79M$ 10.05M
Gross Profit
$ 0.00$ 1.43M$ 1.63M$ 4.62M$ 5.12M
Operating Expenses
$ 92.34M$ 42.38M$ 17.43M$ 12.01M$ 8.56M
Depreciation and Amortization
$ 0.00$ 981.00K$ 344.00K$ 248.00K$ 9.00K
EBITDA
$ 10.46M$ -39.96M$ -14.84M$ -7.39M$ -3.43M
Operating Income
$ 10.46M$ -40.94M$ -15.18M$ -7.39M$ -3.44M
Other Income/Expenses
$ -91.83M$ 835.00K$ 512.00K$ 119.00K$ 50.00K
Pretax Income
$ -81.38M$ -40.11M$ -14.67M$ -7.27M$ -3.39M
Net Income
$ -79.28M$ -46.51M$ -14.67M$ -7.15M$ -3.19M
Per Share Metrics
Basic EPS
$ -1.23$ -0.85$ -0.27$ -0.13$ -0.06
Diluted EPS
$ -1.23$ -0.85$ -0.27$ -0.13$ -0.06
Weighted Average Shares Outstanding
64.42M 54.91M 54.91M 54.91M 54.91M
Weighted Average Shares Outstanding (Diluted)
64.42M 54.91M 54.91M 54.91M 54.91M
Currency in USD

Perspective Therapeutics Earnings and Revenue History